PropeciaPrice.com - Differential Drug Prices

Differentials of drug prices and solvency Danzon and Furukawa (2003) compared average price levels for pharmaceutical products in eight countries - Canada, Chile, France, Germany, Italy, Japan, Mexico and the united kingdom - in relation to those in the United States. The authors used as its unit of the analysis the "molecule announcement" for drugs, defines by active ingredient and therapeutic category. The price of a country per dose was the volume-loaded average cost per the dose, average computed over all package sizes, CROSS national in a molecule announcement with United States volume weights for those comparisons. The priceswere manufacturer uses in place of the retail prices, in order to settle the price data of CROSS national differences inwholesale, of the small price impacts and from the taxes to. With 1999 foreign exchange rates to convert all prices into U.S. dollar of equivalents the authors that of Japan average drug prices per moleculeindication in this year in the nine-countries Kohorte the highest were, found United States prices were the following highest and of Canada lowest, with 33% below United States the prices. Prices in France were 30%, which are lower as United States prices, and prices in the other countries over 15% lower (Danzon and Furukawa 2003, exhibition 3). 44 Uwe E. Reinhardt When CROSS-NATIONAL price comparisons with vorherschenden market indirect taxes to be formed, the observed price differentials varies naturally simply with fluctuations in the indirect taxes, which are affected heavily by fluctuations in the main rivers. In order to avoid this outside source of the deviation in the data, Danzon and Furukawa used two alternative indirect taxes at prices in the foreign currencies into U.S. dollar equivalent prices to convert: (1) rough domestic product purchase energy parity (PPP) indirect taxes and (2) health Obacht Care PPP indirect taxes. The UNION of police PPP indirect taxes adjusts the purchasing power of the different currencies in a Union of Police-created basket by goods and expressed by services, while the health Obacht Care PPP adjusts the purchasing power of the different currencies in a basket expressed by health care goods and services. With the UNION of police PPP transformation the authors that of Canada were average drug prices only 14% below comparable United States the prices 1999, found 33% something suggested instead of at market exchange rates.With the Union of Police Union of Police PPPs, priceswere drug of Japan average belowthe comparableU.S. Prices, although prices of France were approximately 40% below United States the prices, instead of the 30% with market indirect taxes. Germany were average drug prices 25% below United States the prices with UNION of police PPP indirect taxes, instead of approximately 15% with market indirect taxes. Finally with Obacht Care PPP Umrechnugssaetzen, all eight countries in the study higher drug prices than comparable United States prices had the health. This was so because the prices of health care goods and services differently as regulation drugs inthese countrieswere more evenlower than comparable prices in the United States. The locking adjustment, which by Danzon and Furukawa was stopped to that CROSS-NATIONAL differentials in the drug prices, should refer it on CROSS-NATIONAL differences concerning Union of Police by capita, a quite good announcement of the solvency. The authors found that, to this locking adjustment, drug price differentials reflected income differences between countries approximately (except Chile and Mexico). If one treats, global R&D costs as "global common by the efficient and fair global determining strategies again to be brought in costs,", there the authors suggested, then the vorherschenden price differentials were appropriate, if not perfectly, continuously with efficiency and cheapness. From the perspective of the trade switchings, this is in high degrees politics-relevant finding. It suggests that the vorherschenden CROSS-NATIONAL price differentials, far of a representing of the unfair Moochings on the part of other countries, reflect really rather near one of the objectives, which frequently by the critics of the present global drug determining politics are quoted that CROSS-NATIONAL drug prices CROSS-NATIONAL differences concerning the solvency reflect should.